Shanchol

PreclinicalBiologic

EEuBiologics Co.,Ltd

Shanchol is one of 9 biologic programs targeting Pregnant Women. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Pregnant WomenTerminated

Pregnant WomenPreclinical

Terminated

Competition

Competitive Landscape

10 competitors in Pregnant Women

#DrugCompanyPhaseTrials

Vemlidy

Gilead

Approved

1 2

Tirosint

IInstitut Jerome Lejeune

Approved

1 3

Hecolin ).

IInternational Vaccine Institute

Phase 2

1 4

Nicotinamide

MMetro International Biotech, LLC

Preclinical

1 5

IV Acetaminophen

AAFT Pharmaceuticals, Ltd.

Preclinical

1 6

Choline Bitartrate

UUniversity of Minnesota

Preclinical

1 7

Tdap Vaccine

Sanofi

Preclinical

—8

Antiemetic Drug

UUniversity of West Attica

Preclinical

1 9

Shanchol

EEuBiologics Co.,Ltd

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Immunogenicity3 trials

Safety and Immunogenicity of Locally Manufactured Oral Cholera Vaccine

Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 2·NCT02742558·2,052 enrolled

To Evaluate the Efficacy (Immunogenicity) and Safety of Euvichol in Healthy Adults and Children

Completed·EEuBiologics Co.,Ltd·Phase 3·NCT02164110·3,632 enrolled

Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera Vaccine

Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 1/2·NCT02823899·840 enrolled

Vaccine3 trials

Introduction of Cholera Vaccine in Bangladesh

Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·N/A·NCT01339845·240,000 enrolled

Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™

Completed·IInternational Vaccine Institute·Phase 3·NCT04760236·2,530 enrolled

Cholera Vaccine Investment Strategy in Bangladesh

Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh··NCT02727855·75,170 enrolled

1 more indication

Unspecified1 trial

PXVX0200 (CVD103-HgR) vs Shanchol in Mali

Completed·UUniversity of Maryland, Baltimore·Phase 2·NCT02145377·150 enrolled

Sources

References

[1]
ClinicalTrials.gov — 10 trial records for Shanchol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Shanchol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Shanchol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — EuBiologics Co.,Ltd company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: EEuBiologics Co.,Ltd

Shanchol

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Immunogenicity3 trials

Vaccine3 trials

Adult1 trial

Pregnant Women1 trial

Single Dose1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News